The Strategy‑Science & Technology Committee constitutes a distinctive component of the Company and represents one of its core assets and competitive strengths. It is responsible for corporate strategic planning and major scientific‑technological decision‑making. Its responsibilities include formulating 3‑/5‑year plans, annual objectives, budgets and work guidelines, as well as project initiation and in‑process decision‑making. In parallel, it provides end‑to‑end technical guidance for specialized research design, outcome evaluation and risk control across all workflows.

Members of the Strategy‑Science & Technology Committee are heavyweight figures within the pharmaceutical industry, bringing together top‑tier experts spanning major global markets. Their experience and profound expertise cover core links across the entire industrial chain, including regulatory authorities, pharmaceutical enterprises, R&D, clinical development and medical institutions. This forms a full‑dimensional professional support system ranging from policy formulation and new‑drug creation through to clinical translation.